{"title":"Primary Pancreatic Tuberculosis: A Rare Case Report","authors":"T. Elamurugan","doi":"10.19080/argh.2019.13.555858","DOIUrl":null,"url":null,"abstract":"Tuberculosis (TB) is a worldwide public health problem, which has a diverse mode of presentation and the diagnosis is difficult and delayed in some rarer presentations [1]. In India, the incidence of TB in 2015 was 217 per lakh population and the mortality due to TB was 36 per lakh population. Primary Pancreatic tuberculosis (PPTB) is a rare entity among patients with extra-pulmonary TB [2]. Isolated pancreatic TB is predominantly observed in patients who reside in endemic TB zones, in areas of widespread TB dissemination such as a military setting and patients in developing countries who are immuno-compromised.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced research in gastroenterology & hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/argh.2019.13.555858","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Tuberculosis (TB) is a worldwide public health problem, which has a diverse mode of presentation and the diagnosis is difficult and delayed in some rarer presentations [1]. In India, the incidence of TB in 2015 was 217 per lakh population and the mortality due to TB was 36 per lakh population. Primary Pancreatic tuberculosis (PPTB) is a rare entity among patients with extra-pulmonary TB [2]. Isolated pancreatic TB is predominantly observed in patients who reside in endemic TB zones, in areas of widespread TB dissemination such as a military setting and patients in developing countries who are immuno-compromised.